As IL-6 is produced and secreted from adipose tissue, which in turn stimulates CRP production from the liver, one would expect elevated levels of both indicators in the presence of obesity, increasing the likelihood of significant associations with clustered cardiometabolic risk. The gene discussed is IL6; the disease is obesity disorder.